Diagnostics News and Research

RSS

Cernostics, Geisinger announce personalized healthcare collaboration

Cernostics Inc., a biotechnology firm specializing in advanced cancer diagnostics, and Geisinger Health System, a $2.1 billion integrated health services organization, today announced a partnership in personalized healthcare. They will focus on developing diagnostic technologies to detect subtle differences in the cellular and molecular makeup of patient tissue samples. These technologies promise to more effectively predict disease progression and identify patients who are most likely to be receptive to specific cancer treatments.

22 Jun 2010

CardioGenics announces clinical test sites for QL Care portable blood analyzer

CardioGenics Holdings Inc., developer of the ultra-sensitive QL Care™ Point-Of-Care (POC) analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced the selection of four sites for clinical testing of its patented QL Care™ Analyzer, a portable diagnostic platform designed to produce test results with central lab-like accuracy in 15 minutes using whole blood.

21 Jun 2010

FDA approves Abbott's ARCHITECT HIV Ag/Ab Combo assay

Every nine and a half minutes, someone in the United States is infected with HIV, and one out of every five of these individuals doesn't know it. To help stem the spread of this disease, the U.S. Food and Drug Administration (FDA) today approved an innovative new diagnostic tool, which will allow patients to be diagnosed earlier than ever before.

21 Jun 2010

Saladax Biomedical, Bristol-Myers Squibb collaborate to develop clinical diagnostics

Saladax Biomedical, Inc. announced today that it has entered into a multi-year development and commercialization agreement with Bristol-Myers Squibb Company for the development of certain clinical diagnostic tests to be used in conjunction with the development of certain therapeutic compounds in the Bristol-Myers Squibb pipeline.

21 Jun 2010

Dako, Omnyx partner to develop clinical algorithms for digital pathology

Dako, a Danish-based world leader in tissue-based cancer diagnostics, and Omnyx, a leader in digital pathology solutions, announced today that they have entered into a three-year agreement to develop clinical algorithms for digital pathology. The aim is to support pathologists in generating even more accurate, objective and reproducible diagnostic results.

21 Jun 2010

Exiqon licenses LNA technology to BD for diagnosing infectious diseases

Exiqon A/S, today announced that it has granted a non-exclusive license to BD to use Exiqon's proprietary locked nucleic acids technology in defined products for infectious disease diagnostics.

From BD (Becton, Dickinson and Company) 21 Jun 2010

Bracco release confirms Positron's market growth prediction of cardiac PET

Positron Corporation, a leader as a molecular imaging and solutions company specializing in the field of Nuclear Cardiology, cites an article posted on AuntMinnie.com, the largest community website for medical imaging professionals, relating to the growth in cardiac PET.

19 Jun 2010

CPRIT awarded $142M in grants to fund cancer research and prevention programs across the state

The Cancer Prevention and Research Institute of Texas today awarded $142 million in grants to fund innovative cancer research and prevention programs across the state. Today's announcement caps the first year of the Institute's ten year mission. Together with matching funds committed by grant recipients, more than $300 million has been invested this year in Texas' extraordinary endeavor to change the face of cancer.

19 Jun 2010

CardioGenics Holdings files Certificate of Change with the Secretary of State of Nevada

CardioGenics Holdings Inc., developer of the ultra-sensitive QL Care Point-Of-Care analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced today that the Company has filed a Certificate of Change with the Secretary of State of Nevada, which implements a share consolidation of the Company's authorized and outstanding common stock on a ten (old) for one (new) basis.

19 Jun 2010

Applied BioCode's novel BMB technology to be presented at Biodetection Technologies 2010 Conference

Applied BioCode, Inc. announced today a presentation to be given on their Barcoded Magnetic Beads technology at the Biodetection Technologies 2010 Conference in Arlington, Virginia. The presentation is titled "Multiplexed Assays Go Digital" and will be given by Dr. Winston Ho, President at Applied BioCode, on June 18, 2010.

18 Jun 2010

Bone samples act as the ultimate biomarker for environmental pollution: Researchers

Exposure to chemical pollutants is of growing concern to regulators, health workers, and environmentalist groups alike. Now, researchers in the US and Russia have demonstrated that samples of human bone can act as a biological marker for dozens of metals and toxic elements across the periodic table. They describe details in a study published in the International Journal of Environment and Health.

18 Jun 2010

Gen-Probe invests $50M in Pacific Biosciences

Gen-Probe Incorporated and Pacific Biosciences announced today that Gen-Probe has made a $50 million strategic investment in Pacific Biosciences, a private sequencing company. In addition, the companies will work together to explore co-development of new integrated clinical diagnostics systems based on Pacific Biosciences' Single Molecule Real Time (SMRT™) platform and Gen-Probe's expertise in diagnostics.

18 Jun 2010

NuGEN Technologies receives State of California cGMP certification

NuGEN Technologies, the provider of innovative RNA and DNA amplification and sample preparation technologies for breakthrough genomic analysis, today announced it has received the State of California cGMP (current Good Manufacturing Practices) certification following a rigorous audit process. NuGEN is one of the first sample preparation companies to receive this certification, which allows the company to manufacture and ship any of its products under cGMP compliance.

17 Jun 2010

2009 H1N1 pandemic influenza vaccine protects against 1918 influenza virus: Report

Mice injected with a 2009 H1N1 pandemic influenza vaccine and then exposed to high levels of the virus responsible for the 1918 influenza pandemic do not get sick or die, report scientists funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

17 Jun 2010

FDA seeks public input on regulation of laboratory-developed tests

The U.S. Food and Drug Administration today announced plans to hold a public meeting on July 19-20, 2010, to discuss how the agency will oversee laboratory-developed tests (LDTs).

17 Jun 2010

UC researchers receive $2.3M grant to develop user-friendly diagnostics for influenza virus

Researchers at the University of Cincinnati have received a five-year grant to develop rapid, robust, user-friendly diagnostics for influenza virus. An interdisciplinary team of scientists has received a $2.3 million dollar grant from the National Institute for Allergy and Infectious Diseases, one of the National Institutes of Health. The name of the grant is "Glycan Receptor Mimics for Rapid Detection, Typing, and Susceptibility Testing of Influenza."

17 Jun 2010

Gamma-Dynacare to implement SQI's SQiDworks diagnostics platform

SQI Diagnostics Inc., a medical systems company focused on evolving laboratory-based biomarker testing, today announced that Gamma-Dynacare Medical Laboratories, one of Canada's largest providers of laboratory services, has agreed to put into operation SQI's SQiDworks(TM) platform, and to purchase SQI's multiplexed IgXplex(TM) Rheumatoid Arthritis consumables to meet its commercial needs.

17 Jun 2010

Health Care IT market set for continued growth over next five years: Compass Intelligence

New research from Compass Intelligence shows that the Health Care IT market is primed for continued growth over the next five years. Compass Intelligence expects health care organizations including hospitals, doctors' offices, private practices, clinics and other health care organizations to spend an estimated $73.1 Billion this year on IT products, services and solutions.

16 Jun 2010

AVEO granted patents for tests to identify cancer patients likely to respond to tivozanib

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the issuance of U.S. Patent Nos. 7,615,353, which issued in November 2009, and 7,736,861, which issued yesterday.

16 Jun 2010

Vitro, HemoGenix launch new stem cell testing products at International Society for Stem Cell Research meeting

Vitro Diagnostics, Inc., dba Vitro Biopharma, and HemoGenix®, Inc. announced the launch of new high performance stem cell testing products at the International Society for Stem Cell Research annual meeting being held in San Francisco, CA this week. This meeting is being attended by over 3,000 participants from leading academic institutions and commercial stem cell firms throughout the world.

16 Jun 2010

Diagnostics News and Research

Cernostics, Geisinger announce personalized healthcare collaboration

CardioGenics announces clinical test sites for QL Care portable blood analyzer

FDA approves Abbott's ARCHITECT HIV Ag/Ab Combo assay

Saladax Biomedical, Bristol-Myers Squibb collaborate to develop clinical diagnostics

Dako, Omnyx partner to develop clinical algorithms for digital pathology

Exiqon licenses LNA technology to BD for diagnosing infectious diseases

Bracco release confirms Positron's market growth prediction of cardiac PET

CPRIT awarded $142M in grants to fund cancer research and prevention programs across the state

CardioGenics Holdings files Certificate of Change with the Secretary of State of Nevada

Applied BioCode's novel BMB technology to be presented at Biodetection Technologies 2010 Conference

Bone samples act as the ultimate biomarker for environmental pollution: Researchers

Gen-Probe invests $50M in Pacific Biosciences

NuGEN Technologies receives State of California cGMP certification

2009 H1N1 pandemic influenza vaccine protects against 1918 influenza virus: Report

FDA seeks public input on regulation of laboratory-developed tests

UC researchers receive $2.3M grant to develop user-friendly diagnostics for influenza virus

Gamma-Dynacare to implement SQI's SQiDworks diagnostics platform

Health Care IT market set for continued growth over next five years: Compass Intelligence

AVEO granted patents for tests to identify cancer patients likely to respond to tivozanib

Vitro, HemoGenix launch new stem cell testing products at International Society for Stem Cell Research meeting

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News